Merck settles Vioxx claims for $4.85bn
New York, November 9, 2007
Merck has agreed to pay $4.85 billion to settle US claims of heart attacks and strokes allegedly linked to its withdrawn painkiller Vioxx, the drugmaker said.
The agreement was reached with law firms on the steering committee for the federal Vioxx litigation as well as representatives of plaintiffs' counsel in state proceedings, Merck said.
It was signed after the parties met with three of the four judges overseeing the coordination of more than 95 per cent of the current claims in the Vioxx litigation, Merck said.
Merck said the deal is not a class action settlement and claims will be evaluated on an individual basis. Reuters
Tags: Merck |
More Health & Environment Stories
- Abu Dhabi to host mHealth summit
- DHA unveils roll out plan for health insurance
- Dubai hospital performs new pinhole surgery
- Al Ain Civil Defence ties up with disabilities centre
- ADWEA strategic partner for water summit
- Conference to focus on HSE issues
- Deadly human MERS virus also infects camels
- Axa Gulf launches medical provider locator
- Saudi medical devices market to hit $1.6bn
- Bahrain clamp on fitness drugs